Harold Goldenberg

626 total citations
29 papers, 488 citations indexed

About

Harold Goldenberg is a scholar working on Molecular Biology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Harold Goldenberg has authored 29 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Pharmacology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Harold Goldenberg's work include Inflammatory mediators and NSAID effects (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Harold Goldenberg is often cited by papers focused on Inflammatory mediators and NSAID effects (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Harold Goldenberg collaborates with scholars based in United States, Malaysia and Sweden. Harold Goldenberg's co-authors include Inge M. Michel, Don N. Harris, Russell Hilf, Mark Chasin, Sidney M. Hess, Steven M. Seiler, Anders Hedberg, Maria L. Webb, Ira Weinryb and Charles A. Free and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Harold Goldenberg

27 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harold Goldenberg United States 14 218 101 80 78 74 29 488
Yukio Motoyama Japan 14 136 0.6× 124 1.2× 95 1.2× 125 1.6× 142 1.9× 39 641
Junji Yamanishi Japan 11 496 2.3× 134 1.3× 109 1.4× 134 1.7× 163 2.2× 15 901
James A. Lynham United Kingdom 13 420 1.9× 177 1.8× 45 0.6× 141 1.8× 68 0.9× 14 590
Vittorio Anania Italy 14 179 0.8× 193 1.9× 88 1.1× 78 1.0× 71 1.0× 26 682
Barry Cooper United States 13 259 1.2× 136 1.3× 182 2.3× 137 1.8× 132 1.8× 18 697
Armel Fradin France 10 249 1.1× 36 0.4× 91 1.1× 89 1.1× 36 0.5× 14 524
Josée Sraer France 12 190 0.9× 71 0.7× 108 1.4× 99 1.3× 18 0.2× 18 461
A Stierlé France 11 127 0.6× 150 1.5× 57 0.7× 32 0.4× 181 2.4× 16 530
Paul Sargeant United Kingdom 9 287 1.3× 46 0.5× 19 0.2× 82 1.1× 91 1.2× 9 525
F. S. TJOENG United States 9 157 0.7× 54 0.5× 53 0.7× 179 2.3× 48 0.6× 15 468

Countries citing papers authored by Harold Goldenberg

Since Specialization
Citations

This map shows the geographic impact of Harold Goldenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold Goldenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold Goldenberg more than expected).

Fields of papers citing papers by Harold Goldenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harold Goldenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold Goldenberg. The network helps show where Harold Goldenberg may publish in the future.

Co-authorship network of co-authors of Harold Goldenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Harold Goldenberg. A scholar is included among the top collaborators of Harold Goldenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harold Goldenberg. Harold Goldenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hilf, Russell, et al.. (2015). Some Biochemical Characteristics of Rodent and Human Mammary Carcinomas*. PubMed. 11(1). 162–178.
2.
Seiler, Steven M., et al.. (1995). Inhibition of thrombin and SFLLR-peptide stimulation of platelet aggregation, phospholipase A2 and Na+/H+ exchange by a thrombin receptor antagonist. Biochemical Pharmacology. 49(4). 519–528. 35 indexed citations
3.
Meanwell, Nicholas A., Piyasena Hewawasam, James A. Thomas, et al.. (1993). Inhibitors of blood platelet cAMP phosphodiesterase. 4. Structural variation of the side-chain terminus of water-soluble 1,3-dihydro-2H-imidazo[4,5-b]quinolin-2-one derivatives. Journal of Medicinal Chemistry. 36(22). 3251–3264. 9 indexed citations
4.
5.
Harris, Don N., Inge M. Michel, Harold Goldenberg, et al.. (1992). Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.. Journal of Pharmacology and Experimental Therapeutics. 261(1). 131–137. 3 indexed citations
6.
Misra, Raj N., et al.. (1992). Interphenylene phenyl oxazoles: novel, potent thromboxane receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 2(9). 937–940.
7.
Seiler, Steven M., Harold Goldenberg, Inge M. Michel, John T. Hunt, & George B. Zavoico. (1991). Multiple pathways of thrombin-induced platelet activation differentiated by desensitization and a thrombin exosite inhibitor. Biochemical and Biophysical Research Communications. 181(2). 636–643. 32 indexed citations
8.
Misra, Raj N., Philip M. Sher, Manorama M. Patel, et al.. (1991). Interphenylene 7-oxabicyclo[2.2.1]heptanes. SQ33,961: a new potent, long-acting thromboxane antagonist. Bioorganic & Medicinal Chemistry Letters. 1(9). 461–464. 3 indexed citations
9.
Schumacher, William A., Christopher L. Heran, Harold Goldenberg, Don N. Harris, & Martin L. Ogletree. (1989). Magnitude of thromboxane receptor antagonism necessary for antithrombotic activity in monkeys. American Journal of Physiology-Heart and Circulatory Physiology. 256(3). H726–H734. 16 indexed citations
10.
Schumacher, William A., Harold Goldenberg, Don N. Harris, & Martin L. Ogletree. (1987). Effect of thromboxane receptor antagonists on renal artery thrombosis in the cynomolgus monkey.. Journal of Pharmacology and Experimental Therapeutics. 243(2). 460–466. 10 indexed citations
11.
Antonaccio, Michael J., Don N. Harris, & Harold Goldenberg. (1984). Differences in kidney renin content between normotensive and spontaneously hypertensive rats: Effect of captopril treatment. European Journal of Pharmacology. 103(1-2). 157–159. 2 indexed citations
12.
Harris, Don N., et al.. (1984). Effects of SQ 27,427, a thromboxane A2 receptor antagonist, in the human platelet and isolated smooth muscle. European Journal of Pharmacology. 103(1-2). 9–18. 14 indexed citations
13.
14.
Harris, Don N., Christopher L. Heran, Harold Goldenberg, et al.. (1978). Effects of SQ 14,225, an orally active inhibitor of angiotensin-converting enzyme on blood pressure, heart rate and plasma renin activity of conscious normotensive dogs. European Journal of Pharmacology. 51(4). 345–349. 31 indexed citations
15.
Goldenberg, Harold. (1974). 'Moyamoya' associated with peripheral vascular occlusive disease.. Archives of Disease in Childhood. 49(12). 964–966. 19 indexed citations
16.
Harris, Don N., et al.. (1973). Effect of cyclic nucleotides on activity of cyclic 3′,5′-adenosine monophosphate phosphodiesterase. Biochemical Pharmacology. 22(2). 221–228. 31 indexed citations
17.
Weinryb, Ira, Mark Chasin, Charles A. Free, et al.. (1972). Effects of Therapeutic Agents on Cyclic AMP Metabolism In Vitro. Journal of Pharmaceutical Sciences. 61(10). 1556–1567. 75 indexed citations
18.
Goldenberg, Harold, et al.. (1969). Biochemical characteristics of mammary glands and mammary tumors of rats induced by 3-methylcholanthrene and 7,12-dimethylbenz(a)anthracene.. PubMed. 29(5). 977–88. 20 indexed citations
19.
Goldenberg, Harold, et al.. (1969). Some Biochemical Characteristics of Human Breast Cancer and Nonmalignant Breast Lesions. Experimental Biology and Medicine. 132(2). 613–617. 8 indexed citations
20.
Hilf, Russell, et al.. (1967). Effect of actidione (cycloheximide) on estrogen-induced biochemical changes in R3230AC mammary tumors, uteri, and mammary glands.. PubMed. 27(8). 1485–93. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yukio Motoyama Breakdown of academic impact, for papers by Junji Yamanishi Breakdown of academic impact, for papers by James A. Lynham Breakdown of academic impact, for papers by Vittorio Anania Breakdown of academic impact, for papers by Barry Cooper Breakdown of academic impact, for papers by Armel Fradin Breakdown of academic impact, for papers by Josée Sraer Breakdown of academic impact, for papers by A Stierlé Breakdown of academic impact, for papers by Paul Sargeant Breakdown of academic impact, for papers by F. S. TJOENG
Rankless by CCL
2026